SEM Biotech’s manufacturing setup is designed around internationally recognized medical device standards and cleanroom discipline.
Read More
Phase-1 capacity target is 384,000,000 tubes/year, with expansion planned through continued investment and broader product types.
Read More
End-to-end manufacturing covers injection, filling, closure and assembly steps, supported by globally recognized partners for critical components.
Read More